title: Strategies to link innate and adaptive immunity when designing vaccine adjuvants.
abstract: Adjuvants are important components of vaccine formulations. Their functions include the delivery of antigen, recruitment of specific immune cells to the site of immunization, activation of these cells to create an inflammatory microenvironment, and maturation of antigen-presenting cells for enhancement of antigen-uptake and -presentation in secondary lymphoid tissues. Adjuvants include a large family of molecules and substances, many of which were developed empirically and without knowledge of their specific mechanisms of action. The discovery of pattern recognition receptors including Toll-like-, nucleotide-binding oligomerization domain (NOD)- and mannose-receptors, has significantly advanced the field of adjuvant research. It is now clear that effective adjuvants link innate and adaptive immunity by signaling through a combination of pathogen recognition receptors (PRRs). Research in our lab is focused towards the development of novel adjuvants and immunomodulators that can be used to improve neonatal vaccines for humans and animals. Using a neonatal pig model for pertussis, we are currently analyzing the effectiveness of host defence peptides (HDPs), bacterial DNA and polyphosphazenes as vaccine adjuvants.
authors.affiliation: Vaccine & Infectious Disease Organization, Department of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Canada.
authors.forename: Srinivas
authors.initials: S
authors.lastname: Garlapati
authors.forename: Marina
authors.initials: M
authors.lastname: Facci
authors.forename: Monika
authors.initials: M
authors.lastname: Polewicz
authors.forename: Stacy
authors.initials: S
authors.lastname: Strom
authors.forename: Lorne A
authors.initials: LA
authors.lastname: Babiuk
authors.forename: George
authors.initials: G
authors.lastname: Mutwiri
authors.forename: Robert E W
authors.initials: RE
authors.lastname: Hancock
authors.forename: Melissa R
authors.initials: MR
authors.lastname: Elliott
authors.forename: Volker
authors.initials: V
authors.lastname: Gerdts
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D015195:Drug Design; D006801:Humans; D007110:Immunity, Active / Q000276:immunology; D007113:Immunity, Innate / Q000276:immunology; D009838:Oligodeoxyribonucleotides / Q000276:immunology; D009943:Organophosphorus Compounds / Q000276:immunology; D010047:Ovalbumin / Q000737:chemistry; D010316:Particle Size; D011108:Polymers / Q000737:chemistry; D014612:Vaccines / Q000008:administration & dosage / Q000737:chemistry* / Q000276:immunology*
chemical_list: D000276:Adjuvants, Immunologic; D009838:Oligodeoxyribonucleotides; D009943:Organophosphorus Compounds; D011108:Polymers; D014612:Vaccines; D010047:Ovalbumin